Optima Health PLC reported adjusted earnings of £20.1 million for the year to March, exceeding broker Cavendish's forecasts by about 12%. The company benefited from a £4.7 million settlement but also showed improved underlying profitability, with second-half margins rising despite increased costs. Following its £100 million acquisition of PAM Healthcare, Optima is on track to meet its medium-term goals of £200 million revenue and £40 million adjusted earnings. Cavendish raised its price target to 302p, implying a 22% upside from the current share price, and introduced 2029 forecasts projecting continued growth.
Micron Technology has outperformed Nvidia with a 708% gain over the past year, driven by strong demand for high-bandwidth memory critical to AI systems. Analysts see potential for shares to rise from $942 to $1,750 in 2027, supported by rising earnin...
Curtiss-Wright is positioned to benefit from defense modernization through consistent earnings growth driven by component sales and engineering. Key growth areas include modular mission computing, naval production expansion, and improved factory effi...
Nvidia reported a strong Q2 FY2027 with revenue up about 106% year-over-year and forecasted around 70% growth for FY2028. Despite this impressive demand, the stock showed little movement, reflecting cautious investor sentiment due to expected gross m...
The Roundhill Magnificent Seven ETF (MAGS) recently broke out of a multi-month consolidation pattern, signaling potential for significant upward movement beyond its current all-time high. Despite a slight pullback on Friday, technical indicators from...
Oil prices surged to their highest levels in six weeks as tensions escalated between the US and Iran, with both nations exchanging attacks over the weekend. Brent crude rose to $97.52 per barrel, while US West Texas Intermediate briefly surpassed $93...
